NDC 0006-0461

EMEND

Aprepitant

EMEND is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Aprepitant.

Product ID0006-0461_137e0347-9e23-4cc0-a44a-8c88d8983e17
NDC0006-0461
Product TypeHuman Prescription Drug
Proprietary NameEMEND
Generic NameAprepitant
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2003-03-26
Marketing CategoryNDA / NDA
Application NumberNDA021549
Labeler NameMerck Sharp & Dohme Corp.
Substance NameAPREPITANT
Active Ingredient Strength80 mg/1
Pharm ClassesNeurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0006-0461-02

2 CAPSULE in 1 DOSE PACK (0006-0461-02)
Marketing Start Date2003-03-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0006-0461-02 [00006046102]

EMEND CAPSULE
Marketing CategoryNDA
Application NumberNDA021549
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2003-03-26

NDC 0006-0461-06 [00006046106]

EMEND CAPSULE
Marketing CategoryNDA
Application NumberNDA021549
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2003-03-26
Marketing End Date2020-04-30

NDC 0006-0461-12 [00006046112]

EMEND CAPSULE
Marketing CategoryNDA
Application NumberNDA021549
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2003-03-26

NDC 0006-0461-30 [00006046130]

EMEND CAPSULE
Marketing CategoryNDA
Application NumberNDA021549
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2003-03-26
Marketing End Date2010-07-14

NDC 0006-0461-01 [00006046101]

EMEND CAPSULE
Marketing CategoryNDA
Application NumberNDA021549
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2003-03-26

Drug Details

Active Ingredients

IngredientStrength
APREPITANT80 mg/1

OpenFDA Data

SPL SET ID:696f9e80-9cae-403b-de9e-078343ce4713
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1729311
  • 403810
  • 403811
  • 644278
  • 754509
  • 754508
  • 644088
  • 404465
  • 404466
  • 1729308
  • Pharmacological Class

    • Neurokinin 1 Antagonists [MoA]
    • Substance P/Neurokinin-1 Receptor Antagonist [EPC]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 2C9 Inducers [MoA]
    • Cytochrome P450 3A4 Inducers [MoA]

    NDC Crossover Matching brand name "EMEND" or generic name "Aprepitant"

    NDCBrand NameGeneric Name
    0006-0461EMENDaprepitant
    0006-0462EMENDaprepitant
    0006-0464EMENDaprepitant
    0006-3061EMENDFOSAPREPITANT DIMEGLUMINE
    0006-3066EMENDaprepitant
    0006-3862EMENDaprepitant
    0006-3941EMENDEMEND
    42254-160EMENDEMEND

    Trademark Results [EMEND]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    EMEND
    EMEND
    98452421 not registered Live/Pending
    EMEND, LLC
    2024-03-15
    EMEND
    EMEND
    90879357 not registered Live/Pending
    EMEND, LLC
    2021-08-12
    EMEND
    EMEND
    90879262 not registered Live/Pending
    EMEND, LLC
    2021-08-12
    EMEND
    EMEND
    90816895 not registered Live/Pending
    EMEND, LLC
    2021-07-08
    EMEND
    EMEND
    88511573 not registered Live/Pending
    Lonza Ltd.
    2019-07-12
    EMEND
    EMEND
    78449789 3154890 Live/Registered
    Medion Corporation
    2004-07-13
    EMEND
    EMEND
    76254977 2725335 Dead/Cancelled
    Merck & Co., Inc.
    2001-05-10
    EMEND
    EMEND
    75292656 2417822 Live/Registered
    MERCK & CO., Inc.
    1997-05-15
    EMEND
    EMEND
    74619649 2032756 Dead/Cancelled
    CLINITEX MEDICAL CORPORATION
    1995-01-10

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.